Research and Development

A team of researchers and biomedical engineers at Duke University in North Carolina, US, have revealed that they have developed …

Pfizer has revealed that its erectile dysfunction treatment Viagra Connect (sildenafil) will now be available without a prescription through UK …

Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it …

The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of last summer, continuing to grab …

Merck KGaA and Pfizer have been rocked by the news that their jointly-developed anti-PD-L1 antibody failed to meet its primary …

Researchers at the University of Virginia claim they have discovered a new target for triple-negative breast cancer, a notoriously aggressive …

Pharmafocus December edition is available to read online now!

PrimeVigilance is pleased to announce their collaboration with the International Society of Pharmacovigilance (ISoP) on the upcoming seminar, organised by …

Novartis released Phase 3 data on its leading candidate for wet age-related macular degeneration (AMD) drug and it caused a …

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in …

The Veeva European Commercial & Medical Summit will begin tomorrow, seeing more than 800 industry leaders convene at the Marriot …

Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to …

Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …

President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …

As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …